Alfentanil: Simultaneous Testing Pilot



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 40
Updated:12/15/2017
Start Date:October 2009
End Date:September 2016

Use our guide to learn which trials are right for you!

Novel Noninvasive Assessment of Cytochrome P4450 Activity: Simultaneous Testing Pilot

To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A
activity.


Inclusion Criteria:

- Male or non-pregnant female, 18-40 yr. old

- Good general health with no remarkable medical conditions such as liver, kidney,
heart, or lung failure

- BMI between 20-33

- Provide informed consent

Exclusion Criteria:

- Known history of liver or kidney disease

- Use of prescription or non prescription medications, herbals or foods known to be
metabolized by or affect CYP3A (including oral birth control medications)

- Females who are pregnant or nursing

- Known history of drug or alcohol addiction (prior or present addiction or treatment
for addiction)

- Direct physical access to and routine handling of addicting drugs in the regular
course of duty (this is a routine exclusion from studies of drugs with addiction
potential).

- History of bradycardia

- Respiratory rate <10

- History of significant pulmonary disease

- History of pre-existing medical condition predisposing to respiratory depression

- Systolic blood pressure <100 mgHg and diastolic blood pressure <70mmHg
We found this trial at
1
site
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials